We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

AI-Based Tool Improves Diagnosis of Breast Cancer Tumors and Ability to Predict Risk of Recurrence

By MedImaging International staff writers
Posted on 01 Oct 2021
Print article
Illustration
Illustration

Researchers have developed an artificial intelligence (AI)-based tool that improves the diagnosis of breast cancer tumors and the ability to predict the risk of recurrence.

The greater diagnostic precision enabled by the AI-based tool developed by researchers at the Karolinska Institutet (Stockholm, Sweden) can lead to more personalized treatment for the large group of breast cancer patients with intermediate risk tumors.

Every year, around two million women globally develop breast cancer. In the diagnostic procedure, tissue samples of the tumor are analyzed and graded by a pathologist and categorized by risk as low (grade 1), medium (grade 2) or high (grade 3). This helps the doctor determine the most suitable treatment for the patient. Hospitals have recently started to make limited use of molecular diagnostics to improve the precision of breast cancer risk assessment, but these methods are often costly and time-consuming.

In a study based on an extensive microscopic image bank of 2,800 tumors, researchers trained a new AI-based method for tissue analysis to recognize characteristics of high-resolution microscopic images from patients classified with grade 1 and grade 3 tumors. In an evaluation of the AI model, the researchers found that their AI-based method can further divide the patients with grade 2 tumors into two sub-groups, one high-risk and one low-risk that are clearly distinguishable in terms of the recurrence risk. The method is not yet ready for clinical application, but a regulatory approved product is under development. The researchers will now be further evaluating the method with the aim to have a product out on the market by 2022.

“Roughly half of breast cancer patients have a grade 2 tumor, which unfortunately gives no clear guidance on how the patient is to be treated,” said the study’s first author Yinxi Wang, doctoral student at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet. “Consequently, some of the patients are over-treated with chemotherapy while others risk being under-treated. It’s this problem that we’ve tried to resolve.”

“One big advantage of the method is that it’s cost-effective and fast, since it’s based on microscope images of dyed tissue samples, which is already part of hospital procedure,” said co-last author Johan Hartman, professor of pathology at the Department of Oncology-Pathology, Karolinska Institutet, and pathologist at the Karolinska University Hospital. “It enables us to offer this type of diagnosis to more people and improves our ability to give the right treatment to any one patient.”

“It’s fantastic that deep learning can help us develop models that don’t just reproduce what specialist doctors do today, but also enable us to extract information beyond the scope of the human eye,” added co-last author Mattias Rantalainen, associate professor and research group leader at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.

Related Links:
Karolinska Institutet 

New
Gold Supplier
Premium Ultrasound Scanner
ARIETTA 850
New
PACS System
Clario SmartWorklist
Fixed X-Ray System
PerfoX 3000 Eco
Total-Body PET/CT System
uEXPLORER

Print article
CIRS -  MIRION

Channels

Radiography

view channel
Researchers used AI to triage patients with chest pain (Photo courtesy of Pexels)

First Deep Learning AI Model Triages Patients with Chest Pain Using X-Rays

Acute chest pain syndrome can involve tightness, burning or other discomfort in the chest or a severe pain that spreads to the back, neck, shoulders, arms, or jaw, accompanied by shortness of breath.... Read more

Ultrasound

view channel
Image: Dr. Derek Cool demonstrating the new robotic 3D ultrasound system (Photo courtesy of Lawson Health)

Robotic 3D Ultrasound System Improves Accuracy of Liver Cancer Treatment

Liver cancer is the fourth-leading cause of cancer death in the world. Surgery is one treatment option for liver cancer, although thermal ablation which uses heat to destroy the cancerous tumor has less... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

General/Advanced Imaging

view channel
Image: The HIAS-29000 brain PET scanner with motion correction (Photo courtesy of Hamamatsu Photonics)

New Brain PET Scanner Corrects Blurring in Images Caused by Body Motion

Ordinary brain PET (positron emission tomography) scanners are unable to accurately measure the distribution of radiopharmaceuticals in the brain if the patients move their head during the examination process.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.